This Framework Agreement is for the supply of generic and biosimilar cancer medicines to NHS Scotland.
The Goods were separated into forty-one (41) categories, each of which is identified as a “Lot”.
Full details of each awarded Lot is contained in section II.2 of this Notice.

You must be logged in to view the rest of this content, click here to login

Don't have an account, click to sign up for our 14-day free trial.